About Jeff Whitmore
With a career in biotechnology spanning over 25 years, Jeff joins Genezen from mRNA Therapeutic CDMO, TriLink, where he most recently served as Vice President of Commercial Operations and had responsibility for commercial expansion and strategy. Prior to this, Jeff held leadership positions at biostability technology company, Biomatrica, and immunodiagnostics maker, Singulex.
Why Genezen? Genezen’s new facility is state of the art and demonstrates their commitment to being a leader in the development and manufacture of lentiviral and retroviral vectors. It is an exciting time to join the team.
My greatest passion: I am passionate about helping life sciences organizations achieve scalable and sustainable growth and I look forward to injecting this passion into my new role as CCO. Following Genezen’s latest expansion, I look forward to connecting biopharma companies with the capabilities and capacity they need to bring their products to market.
Meet our People
Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.